These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35400081)

  • 21. Effect of Brain Metastasis on Patient-Reported Outcomes in Advanced NSCLC Treated in Real-World Community Oncology Settings.
    Walker MS; Wong W; Ravelo A; Miller PJE; Schwartzberg LS
    Clin Lung Cancer; 2018 Mar; 19(2):139-147. PubMed ID: 29103883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Spinal Appearance Questionnaire: results of reliability, validity, and responsiveness testing in patients with idiopathic scoliosis.
    Sanders JO; Harrast JJ; Kuklo TR; Polly DW; Bridwell KH; Diab M; Dormans JP; Drummond DS; Emans JB; Johnston CE; Lenke LG; McCarthy RE; Newton PO; Richards BS; Sucato DJ;
    Spine (Phila Pa 1976); 2007 Nov; 32(24):2719-22. PubMed ID: 18007251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychometric validation and meaningful change thresholds of the Worst Itching Intensity Numerical Rating Scale for assessing itch in patients with chronic kidney disease-associated pruritus.
    Vernon MK; Swett LL; Speck RM; Munera C; Spencer RH; Wen W; Menzaghi F
    J Patient Rep Outcomes; 2021 Dec; 5(1):134. PubMed ID: 34952964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosscultural Adaptation and Validation of the Korean Version of the New Knee Society Knee Scoring System.
    Kim SJ; Basur MS; Park CK; Chong S; Kang YG; Kim MJ; Jeong JS; Kim TK
    Clin Orthop Relat Res; 2017 Jun; 475(6):1629-1639. PubMed ID: 28265885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychometric evaluation of the Advanced Systemic Mastocytosis Symptom Assessment Form (AdvSM-SAF).
    Taylor F; Li X; Yip C; Padilla B; Mar B; Green T; Oren R; Boral AL; Lin HM; Shields AL; Gotlib J
    Leuk Res; 2021 Sep; 108():106606. PubMed ID: 34004551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Content validity and internal consistency of the Dutch translation of the Safety Attitudes Questionnaire: an observational study.
    Devriendt E; Van den Heede K; Coussement J; Dejaeger E; Surmont K; Heylen D; Schwendimann R; Sexton B; Wellens NI; Boonen S; Milisen K
    Int J Nurs Stud; 2012 Mar; 49(3):327-37. PubMed ID: 22035966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation and reliability of the Dutch version of the EORTC QLQ-NMIBC24 Questionnaire Module for patients with non-muscle-invasive bladder cancer.
    Ripping TM; Westhoff E; Aaronson NK; Van Hemelrijck M; Rammant E; Witjes JA; Kiemeney LA; Aben KKH; Vrieling A
    J Patient Rep Outcomes; 2021 Sep; 5(1):96. PubMed ID: 34542736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A validation study on the traditional Chinese version of Spinal Appearance Questionnaire for adolescent idiopathic scoliosis.
    Guo J; Lau AH; Chau J; Ng BK; Lee KM; Qiu Y; Cheng JC; Lam TP
    Eur Spine J; 2016 Oct; 25(10):3186-3193. PubMed ID: 27167743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is a clinically meaningful change on the Functional Assessment of Cancer Therapy-Lung (FACT-L) Questionnaire? Results from Eastern Cooperative Oncology Group (ECOG) Study 5592.
    Cella D; Eton DT; Fairclough DL; Bonomi P; Heyes AE; Silberman C; Wolf MK; Johnson DH
    J Clin Epidemiol; 2002 Mar; 55(3):285-95. PubMed ID: 11864800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric evaluation of the Indolent Systemic Mastocytosis Symptom Assessment Form (ISM-SAF) in a phase 2 clinical study.
    Padilla B; Shields AL; Taylor F; Li X; Mcdonald J; Green T; Boral AL; Lin HM; Akin C; Siebenhaar F; Mar B
    Orphanet J Rare Dis; 2021 Oct; 16(1):434. PubMed ID: 34663404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clostridium difficile Infection-Daily Symptoms (CDI-DaySyms™) questionnaire: psychometric characteristics and responder thresholds.
    Talbot GH; Kleinman L; Davies E; Hunsche E; Revicki D; Roberts L; Rosenberg D; Nord CE
    Health Qual Life Outcomes; 2019 May; 17(1):77. PubMed ID: 31053093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychometric properties of the Chinese version of the Center for Epidemiologic Studies Depression Scale-Revised in patients with cancer: A cross-sectional study.
    Li J; Zhao F; Bai H; Lin P; Shao D; Sun J; Zhang H; Cao F
    Int J Nurs Stud; 2019 Sep; 97():14-20. PubMed ID: 31129444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.
    Bastyr EJ; Price KL; Bril V;
    Clin Ther; 2005 Aug; 27(8):1278-94. PubMed ID: 16199253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Hong Kong index of dyspepsia: a validated symptom severity questionnaire for patients with dyspepsia.
    Hu WH; Lam KF; Wong YH; Lam CL; HUIi WM; Lai KC; Wong BC; Lam SK
    J Gastroenterol Hepatol; 2002 May; 17(5):545-51. PubMed ID: 12084027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
    Garassino MC; Gadgeel S; Esteban E; Felip E; Speranza G; Domine M; Hochmair MJ; Powell S; Cheng SY; Bischoff HG; Peled N; Reck M; Hui R; Garon EB; Boyer M; Wei Z; Burke T; Pietanza MC; Rodríguez-Abreu D
    Lancet Oncol; 2020 Mar; 21(3):387-397. PubMed ID: 32035514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the Edmonton Symptom Assessment System: Ascites Modification.
    Mori M; Morita T; Yokomichi N; Nitto A; Takahashi N; Miyamoto S; Nishie H; Matsuoka J; Sakurai H; Ishihara T; Tarumi Y; Ogawa A
    J Pain Symptom Manage; 2018 Jun; 55(6):1557-1563. PubMed ID: 29581035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of reliability and validity of the adapted Persian version of the Spinal Appearance Questionnaire in adolescents with idiopathic scoliosis.
    Babaee T; Moradi V; Rouhani N; Shariat A; Parent-Nichols J; Safarnejad H; Nakhaee M
    Spine Deform; 2022 Mar; 10(2):317-326. PubMed ID: 34533776
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reliability and validity of the adapted Turkish version of the Spinal Appearance Questionnaire.
    Yapar A; Yapar D; Ergisi Y; Kaptan AY; Tokgoz MA; Senkoylu A
    Spine Deform; 2021 Jan; 9(1):57-66. PubMed ID: 32808197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of the Presbyopia Impact and Coping Questionnaire.
    Johnson N; Shirneshan E; Coon CD; Stokes J; Wells T; Lundy JJ; Andrae DA; Evans CJ; Campbell J
    Ophthalmol Ther; 2021 Dec; 10(4):1057-1075. PubMed ID: 34643894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.